Tivic Health Secures Patent Validation, Advancing Bioelectronic Medicine for Chronic Sinus Treatment

Tivic Health's Patent Validation Marks a Strategic Advancement in Bioelectronic Medicine

Tivic Health Systems, Inc., a pioneering player in the bioelectronic medicine sector, announces the validation of two key European patents in Great Britain, Germany, and France. This achievement is a significant step in the company’s international market strategy, solidifying its position in the rapidly evolving health technology landscape. The validated patents, EP3615133 and EP3615134, enhance Tivic Health’s capability to deliver innovative treatments for chronic sinus conditions through its flagship product, ClearUP™.

The first patent, EP3615133, focuses on an "Adaptive Trigger For a Microcurrent Stimulation Device." This technology is designed to identify optimal treatment points and trigger the operation of the sinus treatment device, thereby enhancing user experience with programmable options. The second patent, EP3615134, introduces a "Sinus Treatment Device With Adaptive Circuit," which enables real-time adjustments to stimulation voltage during treatment. This innovation is crucial for optimizing comfort and performance, reflecting Tivic Health's commitment to developing effective, user-friendly therapeutic solutions.

Blake Gurfein, Chief Scientific Officer of Tivic Health, highlights the importance of these patent validations as they bolster the company's international patent portfolio, which now totals 16 issued patents and 10 pending patents across multiple regions, including the U.S., Europe, India, and China. With ClearUP™, an FDA-approved handheld device designed for drug-free sinus treatment, Tivic Health aims to provide safe and effective alternatives for individuals suffering from chronic inflammatory conditions. The company's technology targets the trigeminal, sympathetic, and vagus nerve structures, positioning it favorably within the growing bioelectronic medicine market.

In addition to these recent patent validations, Tivic Health's commitment to innovation is evident in its clinically validated approach, which has garnered endorsements from medical professionals. The company’s products are accessible through various online and commercial channels, expanding its reach to consumers seeking non-invasive treatment options.

Tivic Health continues to pave the way for advancements in bioelectronic devices, addressing the increasing demand for effective and low-risk therapeutic alternatives in healthcare. As the company strengthens its international presence, it remains dedicated to improving the quality of life for patients through innovative health technology solutions. For more information, visit http://tivichealth.com.